1 Institute of Brain and Behavior, Department of Psychiatry ... and qualitative rating of medial temporal lobe atrophy (MTA). Outcome measures were Alzheimer type dementia or cognitive decline at ...

One recent analysis found that, over the course of three years, people taking semaglutide (the compound in Ozempic and the weight loss drug Wegovy) were about 40 to 70 percent less likely to be ...

The FDA recently approved Vertex Pharmaceuticals Incorporated’s Journavx (suzetrigine), a first-in-class non-opioid medication for treating moderate to severe acute pain in adults. Journavx, approved ...

By Dr. Chinta Sidharthan Scientists reveal that neurodegenerative diseases aren’t caused by rogue genes, but by the brain’s failing cleanup systems—offering new hope for early detection and treatment.